Bubble Acoustics


Bubble acoustics is a groundbreaking new technique utilised by Dr Cudo and his team at the Sloboda Clinic. It allows the guided transportation and delivery of drugs within the human body, by means of sound wave vibrations propagated by bubbles. The “magic ingredient” is an experimental drug commonly referred to as Fluomephil*.

This is a combination experimental drug based on the composition of “Vitreous Humour” extracted from the donated eyes of the deceased.  Fluomephil will be used to regenerate ocular cell structure and tissue.

The technique has been refined by drawing on insights from Professor Cudo’s medical anthropological field studies of natural healing methods used for millennia by indigenous people in many remote parts of the world.

In short, we are combining the technology of micro gas -filled bubbles only a few nanometres in diameter (less than one hundredth the width of a human hair) – already widely used in allopathic medicine, to enhance ultrasound images – with the ancient wisdom unearthed through decades of anthropological research.

When the micro gas-filled bubbles containing Fluomephil are injected into the bloodstream, they reflect a stronger acoustic signal  through their  echoing vibrations than the surrounding tissue. We have exploited this technology using ultrasound waves of carefully calculated frequencies to guide and track the bubbles accurately through ocular veins to precisely the right part of the  eye. The bubbles are made from lipids filled with a heavy ‘fluorocarbon’ gas, having the advantage of not dissolving easily in the blood stream, thereby ensuring the bubbles containing the Fluomephil stay intact until they reach the correct location within the eye.

The added benefit is that ultrasound can also be used as a detonator at a specific moment using a further higher frequency to explode the bubbles, causing temporary rupture of cell membranes. This helps to release the Fluomephil into the cells where it can be absorbed more effectively.


All this is administered by one simple injection to the temple and then needs a approximate 24 hour transit time for the bubbles to reach the correct location. Then with a simple trigger ultrasound pulse sent remotely via the patients headphones, the bubbles are burst the, the drug is released, and does its work almost instantaneously.


In previous trials only 20% of mice injected with the non-placebo drug showed signs of severe frontal hypothalmic dysfunction!


* lab name Z-0 [mB/1] (patent pending)